Anormal Pigmentasyon ile Bulgu Veren Nörokütan Sendromlar
Özet
Anormal pigmentasyon ile seyreden İnkontinensiya Pigmenti, İto’nun hipomelanozisi, LEOPARD sendromu, Nörokutanöz melanozis, Epidermal nevüs sendromu, Diskeratozis konjenita, Fakomatozis pigmentovaskularis ve Waardenburg sendromu gibi nörokutanöz sendromlar, bu çalışmada detaylı klinik ve genetik özellikleri ile ele alınmaktadır. Söz konusu hastalıklar, deri belirtilerinin yanı sıra göz, merkezi sinir sistemi, iskelet ve diş sistemi gibi çeşitli organ tutulumlarını içeren multisistemik tablolardır. Tanı süreci klinik ve histopatolojik bulgulara dayanmakta olup, bu karmaşık sendromların yönetiminde multidisipliner bir yaklaşım ve genetik danışmanlık kritik öneme sahiptir.
Neurocutaneous syndromes characterized by abnormal pigmentation, such as Incontinentia Pigmenti, Ito's Hypomelanosis, LEOPARD syndrome, Neurocutaneous Melanosis, Epidermal nevus syndrome, Dyskeratosis Congenita, Phakomatosis Pigmentovascularis, and Waardenburg Syndrome, are examined through their clinical and genetic features. These conditions are multisystemic disorders that manifest not only with cutaneous lesions but also with involvement of the eyes, central nervous system, skeleton, and dental structures. Diagnostic procedures rely on clinical and histopathological findings often supported by genetic testing, while effective management requires a multidisciplinary approach and genetic counseling.
Referanslar
Alain T, Fanny MP, Khaled E. Genetic Disorders of Pigmentation. Griffiths CEM,Barker J,Bleiker T,Chalmers R,Creamer D.Rook’s Textbook of Dermatology.Ninth Edition.UK:John Wiley & Sons,Ltd;2016.p70.11
Paller AS,Mancini AJ.Disorders of Pigmentation.Paller AS,Mancini AJ.Hurwitz Clinical Pediatric Dermatology.Fifth Edition.Elsevier;2016.p260-263
Landy SJ, Donnai, D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). Journal of medical genetics,1993; 30(1):53.
Swinney CC, Han DP, Karth PA. Incontinentia pigmenti: a comprehensive review and update. Ophthalmic Surgery, Lasers and Imaging Retina,2015; 46(6), 650-657.
Moss C, Browne F.Mosaicism and Linear Lesions.Bolognia JL,Schaffer JV,Cerroni L.Dermatology,Fourth Edition.Elsevier;2018.p1011-1012.
Scalisi FC, Fusco F, Ursini MV.Incontinencia pigmenti.Actas dermo-sifiliograficas,2019;110(4),273-278.
Greene-Roethke C. Incontinentia pigmenti: a summary review of this rare ectodermal dysplasia with neurologic manifestations, including treatment protocols.Journal of Pediatric Health Care. 2017;31(6):e45-e52.
Baykal C. Genodermatozlar. Dermatoloji Atlası, 4. Baskı. İstanbul: Nobel Tıp Kitabevleri; 2020; p.624-626.
Crowson AN, Margo CM, Jenin A, Barnhill RL. Disorders of Pigmentation.Barnhill RL.Barnhill's Dermatopathology.Fourth Edition.US:McGraw-Hill Education;2020.p461.
Francis JS,Sybert VP.Incontinentia pigmenti.In Seminars in cutaneous medicine and surgery.1997;16(1):54-60.
Calonje E,Brenn T,Lazar AJ,Billings SD.McKee’s Pathology of the Skin.p.706-709.
Minić S,Trpinac D,Obradović M.Incontinentia pigmenti diagnostic criteria update.Clin Genet 2014;85:536.
Scheuerle AE. Incontinentia pigmenti in adults. Am J Med Genet A 2019; 179:1415.
Kaya TI, Tursen U, Ikizoglu G. Therapeutic use of topical corticosteroids in the vesiculobullous lesions of incontinentia pigmenti. Clin Exp Dermatol. 2009; 34:e611.
Cohen J 3rd, Shahrokh K, Cohen B. Analysis of 36 cases of Blaschkoid dyspigmentation: reading between the lines of Blaschko. Pediatr Dermatol 2014; 31:471.
Yücel A.Hipomelanosis İto.Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksungur VL.Dermatoloji. 3. Baskı.İstanbul:Nobel Tıp Kitapevleri;2008;p.1499-1501.
Baykal C. Hipopigmentasyon ile Seyreden Hastalıklar. Dermatoloji Atlası, 4. Baskı. İstanbul: Nobel Tıp Kitabevleri; 2020; p.653-654.
Alain T, Fanny MP, Khaled E. Genetic Disorders of Pigmentation. Griffiths CEM,Barker J,Bleiker T,Chalmers R,Creamer D.Rook’s Textbook of Dermatology.Ninth Edition.UK:John Wiley & Sons,Ltd;2016.p70.10.
Ruggieri M, Pavon L.Topical review:Hypomelanosis of Ito:clinical syndrome or just phenotype?.Journal of child neurology,2000;15(10):635-644.
Akcan AB, Dündar NO, Oygucu S, Haspolat Ş, Oygür N.İto hipomelanozis ve hemimegalensefali birlikteliği:Olgu sunumu.SDÜ Tıp Fakültesi Dergisi,2009;16(2):23-26.
Crowson AN, Margo CM, Jenin A, Barnhill RL. Disorders of Pigmentation.Barnhill RL.Barnhill's Dermatopathology.Fourth Edition.US:McGraw-Hill Education;2020.p455-456.
Ream M.Hypomelanosis of Ito.Handbook of clinical neurology.2015;132:281-289.
Calonje E,Brenn T,Lazar AJ,Billings SD.McKee’s Pathology of the Skin.p.1000-1001.
Ruiz-Maldonado R, Toussaint S, Tamayo L, Laterza A, del Castillo V. Hypomelanosis of Ito: diagnostic criteria and report of 41 cases. Pediatr Dermatol. 1992 Mar;9(1):1-10.
Kalev I, Muru K, Teek R, Zordania R, Reimand T, Köbas K, Õunap K.LEOPARD syndrome with recurrent PTPN11 mutation Y279C and different cutaneous manifestations: two case reports and a review of the literature. European journal of pediatrics,2010;169(4):469-473.
Sarkozy A, Digilio MC, Dallapiccola B.Leopard syndrome. Orphanet journal of rare diseases,2008;3(1):1-8.
Yücel A.LEOPARD Sendromu.Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksungur VL.Dermatoloji. 3. Baskı.İstanbul:Nobel Tıp Kitapevleri;2008;p.1521-1523.
Coppin BD,Temple IK.Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis).Journal of medical genetics,1997;34(7):582-586.
Baykal C. Epidermal Melanositik Tümörler. Dermatoloji Atlası, 4. Baskı. İstanbul: Nobel Tıp Kitabevleri; 2020; p.779.
Calonje E,Brenn T,Lazar AJ,Billings SD.McKee’s Pathology of the Skin.p.1011-1012.
Seuanez H, Mane‐Garzon F, Kolski R.Cardio‐cutaneous syndrome (the “LEOPARD” syndrome). Review of the literature and a new family.Clinical genetics,1976;9(3):266-276.
Voron DA, Hatfield HH, Kalkhoff RK. Multiple lentigines syndrome. Case report and review of the literature. Am J Med. 1976;60:447–456.
Rokitansky J. Ein ausgezeichneter Fall von Pigment-Mal mit ausgebreiteter Pigmentierung der inneren Him- und Riichenmarkshaute. Allg Wien Moo Z 1861;6:1 13-6.
Van Bogaert L. La melanose neurocutanee diffuse heredo- familiale. Bull Acad R Med Belg 1948;13:397-428.
Islam MP. Neurocutaneous melanosis. Handb Clin Neurol. 2015;132:111-7. doi: 10.1016/B978-0-444-62702-5.00007-X. PMID: 26564074.
Foster RD, Williams ML, Barkovich AJ et al. (2001). Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children. Plast Reconstr Surg 107: 933–941.
Becher OJ, Souweidane M, Lavi E et al. (2009). Large congenital melanotic nevi in an extremity with neurocutaneous melanocytosis. Pediatr Dermatol 26: 79–82.
Agero AL, Benvenuto-Andrade C, Dusza SW et al. (2005). Asymptomatic neurocutaneous melanocytosis in patients with large congenital melanocytic nevi: a study of casesfrom an Internet-based registry. J Am Acad Dermatol 53: 959–965.
Lovett A, Maari C, Decarie JC et al. (2009). Large congenital melanocytic nevi and neurocutaneous melanocytosis: one pediatric center’s experience. J Am Acad Dermatol 61: 766–774.
Ramaswamy V, Delaney H, Haque S et al. (2012). Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis. Dev Med Child Neurol 54: 563–568.
Miller VS (2004). Neurocutaneous melanosis. In: ES Roach, VS Miller (Eds.), Neurocutaneous Disorders. Cambridge University Press, Cambridge, pp. 71–76.
Pavlidou E, Hagel C, Papavasilliou A et al. (2008). Neurocutaneous melanosis: report of three cases and up-to-date review. J Child Neurol 23: 1382–1391.
Brandling-Bennett HA, Morel KD. Epidermal nevi. Pediatr Clin North Am. 2010 Oct;57(5):1177-98. doi: 10.1016/j.pcl.2010.07.004. PMID: 20888465.
Wang SM, Hsieh YJ, Chang KM, Tsai HL, Chen CP. Schimmelpenning syndrome: a case report and literature review. Pediatr Neonatol. 2014; 55:487–490
Asch S, Sugarman JL. Epidermal nevus syndromes: New insights into whorls and swirls. Pediatr Dermatol. 2018 Jan;35(1):21-29
Dasegowda SB, Basavaraj G, Nischal K, Swaroop M, Umashankar N, Swamy SS. Becker's Nevus Syndrome. Indian J Dermatol. 2014;59(4):421. doi:10.4103/0019-5154.135530
Biesecker LG, Sapp JC. Proteus Syndrome. 2012 Aug 9 [Updated 2019 Jan 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.
Bittar M, Happle R, Grzeschik K, et al. CHILD Syndrome in 3 Generations: The Importance of Mild or Minimal Skin Lesions. Arch Dermatol. 2006;142(3):348–351. doi:10.1001/archderm.142.3.348
Savage, Sharon A, and Blanche P Alter. “Dyskeratosis congenita.” Hematology/oncology clinics of North America vol. 23,2 (2009): 215-31. doi: 10.1016/j.hoc.2009.01.003
Hasegawa Y, Yasuhara M. Phakomatosis pigmentovascularis type VIa. Arch Dermatol 1985; 121:651-5.
Fernández-Guarino M, Boixeda P, de Las Heras E, Aboin S, García-Millán C, Olasolo PJ. Phakomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature. J Am Acad Dermatol. 2008 Jan;58(1):88-93. doi: 10.1016/j.jaad.2007.08.012. Epub 2007 Nov 28. PMID: 18045734.
Castori M, Rinaldi R, Angelo C, Zambruno G, Grammatico P, Happle R (2008) Phacomatosis cesioflammea with unilateral lipohypoplasia. Am J Med Genet A 146: 492–495.
Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. Review and update of mutations causing Waardenburg Syndrome. Hum Mutat. 2010; 31(4):391-406
